drugset / Trial / NCT00485498

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

NCT00485498

Phase 4 Completed 122 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine whether olanzapine, compared to risperidone, can provide more adequate and timely control of behavioral agitation in acutely ill subjects with schizophrenia.

Timeline

Start
2003-04
Primary completion
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Subject Risperidone Other / unclassified

Indications